Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia

被引：3

作者：

Maeda, Takuya ^{[1
]}

Hiura, Azusa ^{[1
]}

Uehara, Jiro ^{[1
]}

Toyoshima, Rino ^{[1
]}

Nakagawa, Tomoe ^{[1
]}

Yoshino, Koji ^{[1
]}

机构：

[1] Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Dept Dermatol Oncol, Tokyo, Japan

来源：

EUROPEAN JOURNAL OF DERMATOLOGY | 2021年 / 31卷 / 05期

关键词：

JAPANESE PATIENTS; SAFETY;

D O I：

10.1684/ejd.2021.4139

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：662 / 664

页数：3

共 10 条

[1] Frequency of mutations in BRAF, NRAS, and KIT in different populations and histological subtypes of melanoma: a systemic review [J].

Dary Gutierrez-Castaneda, Luz ;

Nova, John A. ;

Tovar-Parra, Jose D. .

MELANOMA RESEARCH, 2020, 30 (01) :62-70

[2] Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma [J].

Fujisawa, Yasuhiro ;

Yoshikawa, Shusuke ;

Minagawa, Akane ;

Takenouchi, Tatsuya ;

Yokota, Kenji ;

Uchi, Hiroshi ;

Noma, Naoki ;

Nakamura, Yasuhiro ;

Asai, Jun ;

Kato, Jiinji ;

Fujiwara, Susumu ;

Fukushima, Satoshi ;

Uehara, Jiro ;

Hoashi, Toshihiko ;

Kaji, Tatsuya ;

Fujimura, Taku ;

Namikawa, Kenjiro ;

Yoshioka, Manabu ;

Murao, Naoki ;

Ogata, Dai ;

Matsuyama, Kanako ;

Hatta, Naohito ;

Shibayama, Yoshitsugu ;

Fujiyama, Toshiharu ;

Ishikawa, Masashi ;

Yamada, Daisuke ;

Kishi, Akiko ;

Nakamura, Yoshiyuki ;

Shimiauchi, Takatoshi ;

Fujii, Kazuyasu ;

Fujimoto, Manabu ;

Ihn, Hironobu ;

Katoh, Norito .

CANCER MEDICINE, 2019, 8 (05) :2146-2156

[3] Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients [J].

Fujisawa, Yasuhiro ;

Yoshino, Koji ;

Otsuka, Atsushi ;

Funakoshi, Takeru ;

Uchi, Hiroshi ;

Fujimura, Taku ;

Matsushita, Shigeto ;

Hata, Hiroo ;

Okuhira, Hisako ;

Tanaka, Ryota ;

Nagai, Kojiro ;

Ishida, Yoshihiro ;

Nakamura, Yoshio ;

Furudate, Sadanori ;

Yamamura, Kentaro ;

Imafuku, Keisuke ;

Yamamoto, Yuki .

JOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 89 (01) :60-66

[4] Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study [J].

Namikawa, Kenjiro ;

Kiyohara, Yoshio ;

Takenouchi, Tatsuya ;

Uhara, Hisashi ;

Uchi, Hiroshi ;

Yoshikawa, Shusuke ;

Takatsuka, Sumiko ;

Koga, Hiroshi ;

Wada, Naoko ;

Minami, Hironobu ;

Hatsumichi, Masahiro ;

Asada, Suguru ;

Namba, Yoshinobu ;

Yamazaki, Naoya .

EUROPEAN JOURNAL OF CANCER, 2018, 105 :114-126

[5] Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy [J].

Rose, April A. N. ;

Armstrong, Susan M. ;

Hogg, David ;

Butler, Marcus O. ;

Saibil, Samuel D. ;

Arteaga, Diana P. ;

Muniz, Thiago Pimentel ;

Kelly, Deirdre ;

Ghazarian, Danny ;

King, Ian ;

Kamil, Zaid Saeed ;

Ross, Kendra ;

Spreafico, Anna .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (01)

[6] Real-world efficacy and safety data of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma [J].

Takahashi, Akira ;

Namikawa, Kenjiro ;

Ogata, Dai ;

Nakano, Eiji ;

Jinnai, Shunichi ;

Nakama, Kenta ;

Tsutsui, Keita ;

Muto, Yusuke ;

Mizuta, Haruki ;

Yamazaki, Naoya .

JOURNAL OF DERMATOLOGY, 2020, 47 (11) :1267-1275

[7] Japanese real-world study of sequential nivolumab and ipilimumab treament in melanoma [J].

Tsutsumida, Arata ;

Fukushima, Satoshi ;

Yokota, Kenji ;

Yoshikawa, Shusuke ;

Yamasaki, Osamu ;

Tanemura, Atsushi ;

Okuyama, Ryuhei ;

Uhara, Hisashi ;

Muto, Yusuke ;

Miyashita, Azusa ;

Akiyama, Masashi ;

Kaji, Tatsuya ;

Koga, Hiroshi ;

Kato, Junji ;

Katayama, Teruaki ;

Itakura, Eijun ;

Yamazaki, Naoya ;

Kiyohara, Yoshio .

JOURNAL OF DERMATOLOGY, 2019, 46 (11) :947-955

[8] Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma [J].

Wolchok, J. D. ;

Chiarion-Sileni, V. ;

Gonzalez, R. ;

Rutkowski, P. ;

Grob, J. -J. ;

Cowey, C. L. ;

Lao, C. D. ;

Wagstaff, J. ;

Schadendorf, D. ;

Ferrucci, P. F. ;

Smylie, M. ;

Dummer, R. ;

Hill, A. ;

Hogg, D. ;

Haanen, J. ;

Carlino, M. S. ;

Bechter, O. ;

Maio, M. ;

Marquez-Rodas, I. ;

Guidoboni, M. ;

McArthur, G. ;

Lebbe, C. ;

Ascierto, P. A. ;

Long, G. V. ;

Cebon, J. ;

Sosman, J. ;

Postow, M. A. ;

Callahan, M. K. ;

Walker, D. ;

Rollin, L. ;

Bhore, R. ;

Hodi, F. S. ;

Larkin, J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14) :1345-1356

[9] Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan [J].

Wu, Chiao-En ;

Yang, Chan-Keng ;

Peng, Meng-Ting ;

Huang, Pei-Wei ;

Lin, Yu-Fen ;

Cheng, Chi-Yuan ;

Chang, Yao-Yu ;

Chen, Huan-Wu ;

Hsieh, Jia-Juan ;

Chang, John Wen-Cheng .

FRONTIERS IN ONCOLOGY, 2020, 10

[10] Efficacy and safety of nivolumab in Japanese patients with previously untreated advanced melanoma: A phase II study [J].

Yamazaki, Naoya ;

Kiyohara, Yoshio ;

Uhara, Hisashi ;

Uehara, Jiro ;

Fujimoto, Manabu ;

Takenouchi, Tatsuya ;

Otsuka, Masaki ;

Uchi, Hiroshi ;

Ihn, Hironobu ;

Minami, Hironobu .

CANCER SCIENCE, 2017, 108 (06) :1223-1230

← 1 →